School of Public Health, North China University of Science and Technology, Tangshan, 063210, Hebei, People's Republic of China.
Baoding Center for Disease Control and Prevention, Baoding, 071030, Hebei, People's Republic of China.
Int J Nanomedicine. 2022 Feb 17;17:713-731. doi: 10.2147/IJN.S338955. eCollection 2022.
The main objective of this study was to clarify the biodistribution and in vivo toxicological effects of indium-tin oxide nanoparticles (Nano-ITO) in male rats.
Dose-response (three divided doses) and time-course studies (six exposure durations) were performed to examine Nano‑ITO-induced pulmonary and systemic toxicity. At the end of the experiment, hematology and serum biochemical parameters were determined, and cytokines levels and oxidative stress were analyzed in the bronchoalveolar lavage fluid. In addition, indium biodistribution following Nano‑ITO exposure was determined using inductively coupled plasma mass spectrometer to measure indium concentration in the lung, spleen, brain, liver, kidney, and testis. Rat lung tissues were also harvested for staining with hematoxylin and eosin, periodic acid Schiff stain, Masson's trichrome, and Sirius red.
Relative lung weights were significantly increased in all Nano-ITO-exposed groups. All organs exhibited a statistically significant difference in indium levels. Rat exposure to Nano‑ITO resulted in a dose-response increase in acute systemic inflammation and injury. BALF analysis revealed significantly elevated levels of lung oxidative stress, pulmonary injury, and inflammatory markers across most groups. Serum biochemistry results showed that Nano-ITO could affect the liver and renal functions of rats when exposed for 3 days. Compared with the control group, significant inflammatory responses or pathological changes were observed in the liver, kidney, and testis of rats at different sampling times and three doses examined. Histopathologically, foci of slight-to-severe pulmonary inflammatory response along with acute inflammatory, pulmonary fibrosis and alveolar proteinosis were detected, and the severity of these lesions worsened in a dose- and time-dependent manner.
These findings provide novel evidence that enhanced progressive massive pulmonary fibrosis, diffuse interstitial fibrosis, and collagen accumulation play a role in the development of pulmonary alveolar proteinosis following Nano-ITO exposure.
本研究的主要目的是阐明铟锡氧化物纳米颗粒(Nano-ITO)在雄性大鼠体内的分布和体内毒理学效应。
进行了剂量反应(三个分剂量)和时间过程(六个暴露持续时间)研究,以检查 Nano-ITO 诱导的肺和全身毒性。实验结束时,测定血液学和血清生化参数,并分析支气管肺泡灌洗液中的细胞因子水平和氧化应激。此外,使用电感耦合等离子体质谱仪测定暴露于 Nano-ITO 后铟的生物分布,以测量肺、脾、脑、肝、肾和睾丸中的铟浓度。还采集大鼠肺组织进行苏木精和伊红染色、过碘酸希夫染色、马松三色染色和天狼猩红染色。
所有暴露于 Nano-ITO 的大鼠的相对肺重均显著增加。所有器官的铟含量均有统计学差异。大鼠暴露于 Nano-ITO 导致急性全身炎症和损伤呈剂量反应性增加。BALF 分析显示,大多数组的肺氧化应激、肺损伤和炎症标志物水平均显著升高。血清生化结果表明,Nano-ITO 暴露 3 天可影响大鼠的肝肾功能。与对照组相比,在不同的采样时间和三个剂量下,大鼠的肝、肾和睾丸均观察到明显的炎症反应或病理变化。组织病理学检查发现,轻度至重度的肺炎症反应灶伴有急性炎症、肺纤维化和肺泡蛋白沉积,这些病变的严重程度呈剂量和时间依赖性增加。
这些发现提供了新的证据,表明增强的进行性大块肺纤维化、弥漫性间质纤维化和胶原积累在 Nano-ITO 暴露后肺肺泡蛋白沉积的发展中起作用。